Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 2, 2007, Pages 136-142

  Spada, Rosario Sebastiano ^a   Stella, Giuseppe ^a   Calabrese, Santa ^a   Bosco, Paolo ^a   Anello, Guido ^a   Guéant Rodriguez, Rosa Maria ^b   Romano, Antonino ^a,b,c   Benamghar, Lahoucine ^b   Fontaine, Thierry ^b   Guéant, Jean Louis ^a,b  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

^b INSERM   (France)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Aging; Folate; Peripheral arteriopathy; Stroke; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; AGED; AMINO ACID BLOOD LEVEL; ANGINA PECTORIS; ARTERY DISEASE; BARTHEL INDEX; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; HEART INFARCTION; HUMAN; INTERVIEW; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE; TUMOR; VEIN THROMBOSIS; VITAMIN BLOOD LEVEL; AGING; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; MIDDLE AGED; NEOPLASM; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY;

ANGINA;

AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FOLIC ACID; HOMOCYSTEINE; HUMANS; MIDDLE AGED; NEOPLASMS; PERIPHERAL VASCULAR DISEASES; SICILY; VITAMIN B 12;

EID: 33847171088     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.065     Document Type: Conference Paper

References (42)

1. Beer J, De Jong A. National population scenarios for countries of the European Economic Area. Maandstat Bevolking 1996;44:7-19.
2. Istituto Nazionale di Statistica (ISTAT). Nota informative 1 agosto, 2006.
3. Bollander-Gouaille C. Focus on homocysteine and the vitamins involved in its metabolism, 2nd ed. Paris: Springer-Verlag, 2002.
4. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
5. Sunderland T, Hill JL, Mellow AM. Clock drawing in Alzheimer's disease. J Am Geriatr Soc 1989;37:725-9.
6. Bosc M, Dubini A, Polin V. Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmacol 1997;7(Suppl 1):S57-70.
7. Lemyre L, Tessier R, Fillion L. Mesure du stress psychologique (M.S.P.): Manuel d'utilisation. Québec, Canada: Behaviora Inc., 1990.
8. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1996;9:179-86.
9. Shah S, Vanclav F, Cooper B. Improving the sensitivity of the Barthel index for stroke rehabilitation. J Clin Epidemiol 1989;42:703-9.
10. Rutten A, Vuillemin A, Ooijendijk WT, Schena F, Sjostrom M, Stahi T, et al. Physical activity monitoring in Europe. The European Physical Activity Surveillance System (EUPASS) approach and indicator testing. Public Health Nutr 2003;6:377-84.
11. Newman AB. Peripheral arterial disease: insights from population studies of older adults. J Am Geriatric Soc 2000;48:1157-62.
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: APA Press, 1994.
13. Brazzelli M, Capitani E, Della Sala E, Spinnler H, Zuffi M. A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment. J Neurosurg Psychiatry 1994;57:1510-7.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
15. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
16. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-8.
17. Tanner CM, Aston DA. Epidemiology of Parkinson's disease and akinetic syndromes. Curr Opin Neurol 2000;13:427-30.
18. Morgante I, Rocca WA, Di Rosa AE, De Domenico P, Gricoletto F, Meneghini F. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology 1992;42:1901-7.
19. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999;52:78-84.
20. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke 2004;35(Suppl 1):2620-2.
21. Ferini-Strambi L, Marcone A, Garancini P, Danelon F, Zamboni M, Massussi P, et al. Dementing disorders in north Italy: prevalence study in Vescovato, Cremona Province. Eur J Epidemiol 1997;13:201-4.
22. Principe M, Casini AR, Ferretti C, Lattanzio MT, Fiorelli M, Culasso F. Prevalence of dementia in an elderly rural population: effect of age, sex and education. J Neurol Neurosurg Psychiatry 1996;60:628-33.
23. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133-42.
24. Di Carlo A, Launer LJ, Breteler MM, Fratiglioni L, Lobo A, Martinez-Lage J, et al. Frequency of stroke in Europe: a collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Disease in the Elderly Research Group. Italia Longitudinal Study on Aging. Neurology 2000;54(Suppl 5):S28-S33.
25. Guéant-Rodriguez RM, Guéant JL, Debard R, Thirion S, Xiao Hong L, Bronowicki JP, et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study among Mexican, West African and West European populations. Am J Clin Nutr 2006;83:701-7.
26. de Bree A, Verschuren WM, Blom HJ, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y. Am J Clin Nutr 2001;73:1027-33.
27. Mennen LI, de Courcy GP, Guilland JC, Ducros V, Bertrais S, Nicolas JP. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 2002;76:1279-89.
28. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-75.
29. Cronin S, Furie K, Kelly P. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 2005;36:1581-7.
30. Bosco P, Guéant-Rodriguez RM, Anello G, Spada R, Romano A, Fajardo A, et al. Association of homocysteine (but not of MTHFR 677 C→T, MTR 2756 A→G, MTRR 66 A→G and TCN2 776 C→G) with ischemic cerebrovascular disease in Sicily. Thromb Haemost 2006;96:154-9.
31. Kelly PJ, Shih VE, Kistler JP, Barron M, Lee H, Mandell R, et al. Low vitamin B6, but not homocyst(e)ine, is associated with increased risk of stroke/TIA in the era of folic acid grain fortification. Stroke 2003;34:51-4.
32. Taylor LM Jr, Moneta GL, Sexton G J, Schuff RA, Porter JM. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 1999;29:8-19.
33. Merchant AT, Hu FB, Spiegelman D, Willett WC, Rimm EB, Ascherio A. The use of B vitamin supplements and peripheral arterial disease risk in men are inversely related. J Nutr 2003;133:2863-7.
34. Lewis SJ, Ebrahim S, Smith GD. Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? Br Med J 2005;331:1053.
35. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-55.
36. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998;13:235-9.
37. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
38. Anello G, Gueant-Rodriguez RM, Bosco P, Gueant JL, Romano A, Namour B. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 2004;15:859-61.
39. Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance, Diabetes Care 2000;23:1816-22.
40. Smulders YM, Rakic M, Slaats EH, Treskes M, Sijbrands EJ, Odekerken DA, et al. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care 1999;22:125-32.
41. Mazza A, Bossone E, Mazza F, Distante A. Reduced serum homocysteine levels in type 2 diabetes. Nutr Metab Cardiovasc Dis 2005;15:118-24.
42. Hermans MP, Gala JL, Buysschaert M. The MTHFR CT polymorphism confers a high risk for stroke to both homozygous and heterozygous T allele carriers with type 2 diabetes. Diabet Med 2006;23:529-36.